Bulletin
Investor Alert

London Markets Open in:

Pfizer Inc.

NYS: PFE

GO
/marketstate/country/us

After Hours

PFE
/zigman2/quotes/202877789/composite

$

36.23

Change

+0.06 +0.17%

Volume

Volume 489,122

Sep 29, 2020, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202877789/composite

Previous close

$ 36.39

$ 36.17

Change

-0.22 -0.60%

Day low

Day high

$36.04

$36.54

Open
Open: 36.43

52 week low

52 week high

$27.88

$40.97

Open

Market cap

$202.21B

Average volume

25.57M

P/E ratio

14.38

Rev. per Employee

$580,595

EPS

2.51

Dividend

0.38

Div yield

4.20%

Ex dividend date

11/5/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pfe

MarketWatch News on PFE

  1. Johnson & Johnson stock outperforms competitors despite losses on the day

    4:25 p.m. Sept. 29, 2020

    - MarketWatch Automation

  2. Johnson & Johnson stock rises Monday, still underperforms market

    4:52 p.m. Sept. 28, 2020

    - MarketWatch Automation

  3. Inovio Stock Tumbles After Covid-19 Vaccine Trial Is Halted

    3:46 p.m. Sept. 28, 2020

    - Bill Alpert

  4. The Pandemic Speeds Up the Health-Care Revolution

    8:56 a.m. Sept. 28, 2020

    - Lauren R. Rublin

  5. Honeywell, General Mills Boost Their Dividends

    7:30 a.m. Sept. 26, 2020

    - Lawrence C. Strauss

  6. Johnson & Johnson stock rises Friday, still underperforms market

    4:25 p.m. Sept. 25, 2020

    - MarketWatch Automation

  7. Covid-19 Vaccine Prices May Be Unexpectedly Low

    1:30 p.m. Sept. 25, 2020

    - Bill Alpert

  8. Novavax Starts a Phase 3 Trial of Its Covid-19 Vaccine

    9:07 a.m. Sept. 25, 2020

    - Bill Alpert

  9. Johnson & Johnson stock rises Thursday, still underperforms market

    4:25 p.m. Sept. 24, 2020

    - MarketWatch Automation

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pfe

Other News on PFE

  1. Pfizer, CStone ink deal for oncology assets in China

    11:57 p.m. Sept. 29, 2020

    - Seeking Alpha

  2. IPO Update: Virios Therapeutics Seeks $30 Million IPO

    5:35 p.m. Sept. 29, 2020

    - Seeking Alpha

  3. Lonza confident on production of Moderna COVID-19 vaccine

    4:02 p.m. Sept. 29, 2020

    - Seeking Alpha

  4. Danger Is Approaching for Coronavirus Vaccine Stocks

    3:12 p.m. Sept. 29, 2020

    - Charley Grant

  5. AbbVie Elezanumab Gets FDA's Fast Track and Orphan Drug Tags

    10:52 a.m. Sept. 29, 2020

    - Zacks.com

  6. Looking Forward

    10:28 a.m. Sept. 29, 2020

    - Seeking Alpha

  7. The World May be Nearing Treatments for the Growing Pandemic

    10:01 a.m. Sept. 29, 2020

    - Baystreet.ca

  8. Why Investors Should Buy Moderna Instead Of Inovio

    8:53 a.m. Sept. 29, 2020

    - Seeking Alpha

  9. Pfizer (PFE) Gains But Lags Market: What You Should Know

    5:45 p.m. Sept. 28, 2020

    - Zacks.com

  10. Scant Vaccine Hopes Aren’t Enough to Make iBio a Buy

    1:01 p.m. Sept. 28, 2020

    - InvestorPlace.com

  11. Inovio Covid-19 Vaccine Trial Placed on Hold After FDA Questions

    12:23 p.m. Sept. 28, 2020

    - Jared S. Hopkins

  12. The Most Dangerous Phrase In The Investing World

    9:27 a.m. Sept. 28, 2020

    - Seeking Alpha

  13. Inovio Stock Still Has Real Promise Despite Faltering in Vaccine Race

    8:40 a.m. Sept. 28, 2020

    - InvestorPlace.com

  14. You Can Go Back to the Office—You Just Need a VR Headset

    7:00 a.m. Sept. 28, 2020

    - Joanna Stern

  15. Loading more headlines...
/news/pressrelease/company/us/pfe

Press Releases on PFE

  1. Dacryocystitis Treatment Market Forecast Based on Major Drivers & Trends Up to 2020

    12:46 a.m. Today

    - Markitwired

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.